Raymond James Financial Inc Xenon Pharmaceuticals Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 63,385 shares of XENE stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,385
Previous 20,331
211.77%
Holding current value
$1.96 Million
Previous $796,000
167.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
220Shares Held
70.3MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$177 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$142 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$117 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$103 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$95.3 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.92B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...